These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33863619)
41. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience. Motamedinia P; Keheila M; Leavitt DA; Rastinehad AR; Okeke Z; Smith AD J Endourol; 2016 Mar; 30(3):262-7. PubMed ID: 26630130 [TBL] [Abstract][Full Text] [Related]
42. Oncological and Renal Function Outcomes in Patients Who Underwent Simultaneous Radical Cystectomy and Nephroureterectomy for Synchronous or Metachronous Panurothelial Carcinoma. Subiela JD; González-Padilla DA; Huguet J; Aumatell J; Rodríguez-Faba O; Krajewski W; Feliu AH; Mínguez C; Plaza JL; Artiles Medina A; Gajate P; Jiménez Cidre MÁ; Burgos Revilla J; Breda A; Palou J Urology; 2023 Feb; 172():157-164. PubMed ID: 36436672 [TBL] [Abstract][Full Text] [Related]
43. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908 [TBL] [Abstract][Full Text] [Related]
44. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis. Yuan H; Chen X; Liu L; Yang L; Pu C; Li J; Bai Y; Han P; Wei Q Urol Oncol; 2014 Oct; 32(7):989-1002. PubMed ID: 25082191 [TBL] [Abstract][Full Text] [Related]
47. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698 [TBL] [Abstract][Full Text] [Related]
48. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. Xylinas E; Colin P; Audenet F; Phe V; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Polguer T; Ruffion A; Valeri A; Rozet F; Long JA; Zerbib M; Rouprêt M World J Urol; 2013 Feb; 31(1):61-8. PubMed ID: 23053211 [TBL] [Abstract][Full Text] [Related]
49. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis. Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888 [TBL] [Abstract][Full Text] [Related]
50. Endoscopic excision versus radical nephroureterectomy for non-muscle invasive upper tract urothelial carcinoma: A population-based large cohort study. Ye Y; Zheng Y; Li J; Miao Q; Lin M; Chen J; Ruan H; Zhang X Heliyon; 2023 Dec; 9(12):e22408. PubMed ID: 38107280 [TBL] [Abstract][Full Text] [Related]
51. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy. Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698 [TBL] [Abstract][Full Text] [Related]
52. Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Ryoo H; Kim J; Kim T; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH Cancer Res Treat; 2021 Jul; 53(3):795-802. PubMed ID: 33421984 [TBL] [Abstract][Full Text] [Related]
53. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy. Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580 [TBL] [Abstract][Full Text] [Related]
54. Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes. Ko YH Transl Cancer Res; 2020 Oct; 9(10):6589-6595. PubMed ID: 35117269 [TBL] [Abstract][Full Text] [Related]
55. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Rodrigues Pessoa R; Morrison JC; Konety B; Gershman B; Maroni P; Kukreja JB; Cost N; Flaig T; Kessler E; Sharma P; Kim SP Urol Oncol; 2021 Dec; 39(12):832.e9-832.e15. PubMed ID: 33820697 [TBL] [Abstract][Full Text] [Related]
56. Oncologic Results of Retroperitoneoscopic Versus Open Surgery for T2 Upper Tract Urothelial Carcinoma. Shan H; Wang X; Sun Q; Chen Q; Xu B; Hao Y; Xu W Clin Genitourin Cancer; 2015 Dec; 13(6):568-73. PubMed ID: 26183657 [TBL] [Abstract][Full Text] [Related]
57. Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration. Bachir BG; Aprikian AG; Izawa JI; Chin JL; Fradet Y; Fairey A; Estey E; Jacobsen N; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Kapoor A; Matsumoto E; Saad F; Bell D; Black PC; So AI; Drachenberg D; Kassouf W Urol Oncol; 2014 May; 32(4):441-8. PubMed ID: 24412632 [TBL] [Abstract][Full Text] [Related]